Comparison 29. EASI versus intracervical prostaglandin E2: all women.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
29.1 Caesarean section	2	155	Risk Ratio (M‐H, Random, 95% CI)	0.73 [0.10, 5.12]
29.2 Cervix unfavourable/unchanged after 12‐24 hours	1	85	Risk Ratio (M‐H, Fixed, 95% CI)	0.06 [0.00, 0.97]
29.3 Oxytocin augmentation	1	70	Risk Ratio (M‐H, Fixed, 95% CI)	1.10 [0.54, 2.25]
29.4 Instrumental vaginal delivery	1	85	Risk Ratio (M‐H, Fixed, 95% CI)	0.33 [0.04, 3.01]
29.5 Apgar score < 7 at 5 minutes	1	0	Risk Ratio (M‐H, Fixed, 95% CI)	Not estimable
29.6 Endometritis	1	0	Risk Ratio (M‐H, Fixed, 95% CI)	Not estimable
29.7 Fetal distress	1	70	Risk Ratio (M‐H, Fixed, 95% CI)	0.29 [0.06, 1.28]